ClinicalTrials.gg
RecruitingNCT05339165FamFINEDUpdated Apr 24, 2024

FAMily Factors INvolved in Eating Disorders

An observational study in Eating Disorders, sponsored by University Medical Center Goettingen. Recruiting at 2 sites in Germany. Open to participants aged 12 Years to 59 Years. Per ClinicalTrials.gov, last updated 2024-04-24.

Sponsored by University Medical Center Goettingen · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2017; still recruiting 9 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
600
Ages
12 Years to 59 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Feeding and Eating Disorders with a site in Germany — 4 open to participants now, 4 under way, none of them phase 3. Feeding and Eating Disorders · Germany.

Started
2017
the only one that year
Observational
5 of 10
2 open now
Registered
6th of 10
by date
Lead sponsor
1 of 10
University Medical Center Goettingen

Among the 10 studies in Feeding and Eating Disorders with a site in Germany, this one is the only one that started in 2017, is one of 5 observational ones, and was the 6th registered.

Feeding and Eating Disorders

645 studies on the registry are indexed under Feeding and Eating Disorders; 151 are open to participants now.

Browse Feeding and Eating Disorders studies →

Open to participants now

4 of the 10 studies in Feeding and Eating Disorders with a site in Germany are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 99 Feeding and Eating Disorders studies recruiting now, 31 (31%) set no upper age limit and 66 (67%) stop at 75 or younger; 45 take children under 18; 20 take healthy volunteers.

This study: 12 Years to 59 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Feeding and Eating Disorders with a site in Germany, or all of them as a file.
02

Study summary

This observational study compares parental age and birth order in patients diagnosed with anorexia nervosa and bulimia nervosa.

Read the detailed description

Study participants are recruited (300 patients for each entity). Healthy subjects without evidence of an eating disorder serve as a control group. Psychometric assessment will include data on pathological eating behavior and general psychological and interpersonal problems.

Outcome measures The SCL-90-R questionnaire is a self-report inventory for adolescents and adults that assesses a wide range of psychological problems and symptoms of psychopathology. The questionnaire consists of 90 items, each of which contributes to one of nine primary symptom dimensions.

The short form of the Inventory of Interpersonal Problems (IIP-C) is used to measure interpersonal problems. This self-report questionnaire contains 64 items assigned to eight subscales.

Eligible candidates are stratified as cases or matched controls as follows:

  1. Cases are eligible patients diagnosed with anorexia nervosa or bulimia nervosa (n=300 for each entity) at the time of study inclusion.
  2. Controls (100) are healthy subjects of a similar age distribution and from the same study site without the diagnosis of an eating disorder.

Inclusion criteria:

  • Age > 12 and \< 59 years (adolescents and adults).

Exclusion criteria:

  • Diagnosed with a malignant disease
  • Not fluent in the German language
  • Severe mental disorder
03

Conditions studied

  • Eating Disorders

Keywords

  • Eating disorder, anorexia nervosa, bulimia nervosa
04

Who can participate

Ages eligible
12 Years to 59 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Study participants with diagnosed anorexia nervosa or bulimia nervosa according to ICD-10 criteria

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 12 and \< 59 years (adolescents and adults) with either anorexia nervosa or bulimia nervosa.

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with a malignant disease
  • Not fluent in the German language
  • Severe mental disorder
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
600 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Interventions

  • BehavioralPsychotherapy
06

What researchers measure

Primary outcomes

  1. SCL-90-R questionnaire

    The SCL-90-R questionnaire is a self-report inventory for adolescents and adults that assesses a wide range of psychological problems and symptoms of psychopathology. The questionnaire consists of 90 items, each of which contributes to one of nine primary symptom dimensions.

    Time frame: One day

  2. Short form of the Inventory of Interpersonal Problems (IIP-C)

    The short form of the Inventory of Interpersonal Problems (IIP-C) is used to measure interpersonal problems. This self-report questionnaire contains 64 items assigned to eight subscales.

    Time frame: One day

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2017 (actual). Primary completion is estimated for Jan 2026, 108 months after the start.

Of 61 non-industry observational studies under Feeding and Eating Disorders, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 95. This study's planned 108 months is above that.

Counting every sponsor, half of 64 studies reached it within 42 months; a quarter within 18 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 14, 2022
First posted
Apr 21, 2022
StartActual
Jan 1, 2017
Primary completionEst.
Jan 2026
CompletionEst.
Mar 2026
Last update
Apr 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05339165
Lead sponsor
University Medical Center Goettingen
Responsible party
Prof. Thomas Meyer (Head of Laboratory, University Medical Center Goettingen) — Principal investigator
First posted
Apr 21, 2022
Start date
Jan 1, 2017
Primary completion
Jan 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
Apr 24, 2024

Study contacts

Thomas Meyer, Prof.
Contact
thomas.meyer@med.uni-goettingen.de
+495513964940
Günter Reich, Prof. Dr.
Contact
greich@gwdg.de
+49551395500
Thomas Meyer
principal investigator · University of Göttingen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion